A 29-year-old woman with documented hereditary angioedema type I presenting 6 hours after third molar extraction with progressive tongue, lip, and laryngeal swelling that has failed intramuscular epinephrine, IV diphenhydramine, and IV methylprednisolone.
Acute Resuscitation Milestones & Priorities
Clinical phases and key interventions encountered in this emergency module:
Initial Resuscitation Bay Assessment & Failed Anaphylaxis Pathway
Escalation to Bradykinin Receptor Blockade & Difficult Airway Preparation
Airway Stabilization & Confirmation of HAE Pathophysiology
Hereditary angioedema attacks are bradykinin-mediated and unresponsive to epinephrine, antihistamines, and corticosteroids. Repeat anaphylaxis-directed therapy in a known HAE patient is a common, lethal cognitive trap.
The diagnostic biochemical triad for HAE type I: low C4, low C1-inhibitor antigen, low C1-inhibitor functional activity. A normal tryptase excludes mast cell activation as the dominant mechanism.
Acute therapy: plasma-derived C1-inhibitor (Berinert, Cinryze), recombinant C1-INH (Ruconest), or icatibant (bradykinin B2 receptor antagonist). Icatibant is contraindicated in acute coronary syndromes due to antagonism of bradykinin's cardiac protective signaling.
Airway management in laryngeal HAE: anticipate difficulty, prepare difficult-airway equipment, perform awake fiberoptic intubation preserving spontaneous ventilation, mark the cricothyroid membrane, and have ENT and anesthesia at bedside before instrumentation.
Cuff leak volume <110 mL predicts extubation failure. Fiberoptic reassessment of edema resolution plus a 24-48 hour observation period is required before extubation in laryngeal HAE.
Long-term prophylaxis options: subcutaneous pdC1-INH (Haegarda), lanadelumab (anti-plasma kallikrein monoclonal antibody, Takhzyro), or berotralstat (oral plasma kallikrein inhibitor, Orladeyo). Attenuated androgens are no longer first-line due to hepatic, endocrine, and oncologic adverse effects.
Every patient with HAE must carry an emergency action plan, on-demand rescue medication (including for travel), MedicAlert jewelry, and be enrolled in a structured allergy/immunology follow-up program.
Trigger avoidance: dental/oropharyngeal trauma, ACE inhibitors (which prevent bradykinin degradation), estrogen-containing contraceptives, and stress are recognized precipitants of attacks.
Test Your Clinical Reasoning in Real Time
Step into the active clinician role for this case. Order diagnostic tests, analyze live laboratory panels, and navigate branching clinical decisions with real-time feedback.